Liposorber

07/27/2026

If you or a loved one has FSGS, you’re not alone 💙

Managing kidney disease often involves:
✅ Regular monitoring
✅ Medications prescribed by your care team
✅ Lifestyle adjustments
✅ Ongoing support

New approaches may be available for select patients who haven’t responded to traditional therapies. Talk to your provider to see if Liposorber is a good fit.

✨ Stay informed. Stay empowered. Ask questions.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

07/24/2026

Did you know there’s a treatment option for select FSGS patients who do not respond to or tolerate standard treatment options?

Liposorber® LA-15 is a FDA-approved Humanitarian Use Device (HUD) for adult and pediatric patients with nephrotic syndrome associated with primary FSGS who haven’t responded to standard therapies.

The treatment works by removing substances in the blood that may play a role in the disease process.

💬 Ask your healthcare provider if this option might be appropriate for you.

Learn more: https://liposorber.com/kidney-disease/liposorber-for-fsgs/

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

07/22/2026

How can treatment help in FSGS? It may start with what’s in your blood.

Liposorber® therapy works by lowering harmful cholesterol (LDL) and other substances that may damage the kidneys.

This may help:
💧 Protect the kidney’s filtering cells
💊 Improve response to certain medications in some patients
🔥 Reduce inflammation linked to kidney damage

For some people with FSGS, this approach may support better disease management alongside standard care.

Learn more: https://liposorber.com/kidney-disease/liposorber-for-fsgs/

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

07/20/2026

There is hope when managing difficult-to-treat FSGS 💙

Studies suggest that Liposorber® therapy may help some patients:
✅ Lower protein levels in urine
✅ Improve response to medications
✅ Support kidney function over time

In fact, up to 50% of patients with treatment-resistant FSGS achieved partial or complete remission in studies. *

Every patient is different, but knowing your options can make a difference.

💬 Talk with your care team to learn more.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

*Based on a study that took place over two (2) years. Reference: Muso, Eri et al. “Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.” Clinical and experimental nephrology vol. 19,3 (2015): 379-86. doi:10.1007/s10157-014-0996-8.

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

07/17/2026

Managing severe high cholesterol when standard medications fail can feel like an uphill battle. LIPOSORBER ® offers a powerful, clinically proven alternative. With four decades of worldwide clinical evidence, our advanced therapy selectively removes low-density lipoprotein cholesterol (LDL-C) and Lipoprotein(a) directly from the blood to help reduce the risk of atherosclerotic cardiovascular disease (ASCVD).

Take control of your heart health. Ask your physician if LIPOSORBER® is right for you, or take our quiz to learn more: https://liposorber.com/cardiovascular-disease/am-i-a-candidate-fh/

For LIPOSORBER Indications for Use and safety information, visit: https://www.liposorber.com/liposorber-safety-info

07/16/2026

Living with or treating a complex, treatment-resistant kidney disease like primary FSGS requires looking beyond traditional options. Liposorber® LA-15 provides an FDA-approved HDE treatment option for adult and pediatric patients with nephrotic syndrome who haven’t responded to standard care. Liposorber may help lower protein levels in the urine and preserve renal function by selectively removing factors from the blood.

Explore new options for refractory FSGS management. Talk to your care team or locate a treatment center near you: https://liposorber.com/find-a-center/

For LIPOSORBER Indications for Use and safety information, visit: https://www.liposorber.com/liposorber-safety-info

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

06/30/2026

As we close out this special month, we want to take a moment to say THANK YOU.
- To the patients who trust us with their care and inspire us every day
- To the families and caregivers who stand beside them
- To the nurses, physicians, and care teams who bring compassion and expertise to
every treatment
- And to everyone behind the scenes who helps make Liposorber® possible.

For 30 years, this journey has been about people - their strength, their stories, and their
hope. We are honored to be part of your journey and grateful for the role we play in supporting you every step of the way.
As we celebrate this milestone, we’d love to hear from the people who matter most - our patients. If Liposorber has been part of your journey, we invite you to share your story,
experience, or words of encouragement. Your voice can help inspire others who are just
beginning.

To share your story, visit: qrco.de/liposorberstory
Thank you to everyone who has been part of the Liposorber journey over the past 30 years, and to all those who will be part of what’s ahead.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

06/17/2026

Back-to-back conference success in Chicago and Boston 👏

Last week, we returned to the NLA Scientific Sessions - always a highlight and a great opportunity to reconnect with customers, strengthen relationships, and expand our network.

Our Expert Theater was a standout moment, featuring Dr. Saxon (University of Colorado) and Dr. Marvel (Johns Hopkins), who walked through a real patient case alongside Terri, who bravely shared her journey. It was standing room only!

We also attended VAM in Boston, a new conference for our team as we continue expanding into the vascular space. It was a valuable opportunity to connect with vascular surgeons, explore the landscape, and share how lipoprotein apheresis can help certain PAD patients.

Two conferences, countless meaningful conversations, and continued momentum 🚀

06/11/2026

Behind Every Treatment, There’s a Care Team That Never Stops Showing Up

For 30 years, Liposorber® has been about more than treatment - it’s about the people
who make it possible every single day.
Nurses like Melissa, Diana, and Jenny, who build lasting relationships, guide patients
through every step, and bring both skill and compassion to the bedside.
Physicians like Dr. Saxon, Dr. Mintz, Dr. Moriarty - who lead with expertise, advocate for
their patients, and push care forward.

These are the people who:
✨ Turn complex care into moments of comfort
✨ Celebrate every small win alongside their patients
✨ Help patients not just live - but live better

Behind every treatment is a team that listens, supports, and believes in what’s possible.
And after 30 years, their impact is still growing. ❤️
For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

06/09/2026

Every Liposorber® treatment tells a story, and over the past 30 years, those stories
have become a powerful reminder of what’s possible.
From Avery, a pediatric HoFH patient who began treatments at a young age and now
dreams of becoming a nurse…
To patients like Salima, a FH patient and Anjelique, a FSGS patient, who found
strength, stability, and hope in the face of life-changing diagnoses…
To Terri, an elevated Lp(a) patient who is using her voice to raise awareness for
Lipoprotein(a) and help others get answers sooner…
To Kate, an FH patient who returned to pursue her PhD after years of uncertainty…
These journeys are different, but they share something powerful:
✨ the ability to reclaim life, find hope, and keep moving forward ✨
For 30 years, Liposorber has not only supported patients, but it has also helped bring
awareness to conditions like FH, elevated Lp(a), and FSGS - ensuring more people can
be seen, diagnosed, and treated.
Key:
HoFH = homozygous familial hypercholesterolemia
FH = familial hypercholesterolemia
FSGS = focal segmental glomerulosclerosis
Lp(a) = lipoprotein(a)
For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.